rs2943512

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002458.3(MUC5B):​c.14116A>C​(p.Thr4706Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.508 in 1,586,920 control chromosomes in the GnomAD database, including 214,695 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 20589 hom., cov: 30)
Exomes 𝑓: 0.51 ( 194106 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.82

Publications

30 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.664287E-6).
BP6
Variant 11-1250996-A-C is Benign according to our data. Variant chr11-1250996-A-C is described in ClinVar as Benign. ClinVar VariationId is 403179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.645 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.14116A>C p.Thr4706Pro missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.14116A>C p.Thr4706Pro missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84

Frequencies

GnomAD3 genomes
AF:
0.517
AC:
76729
AN:
148530
Hom.:
20554
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.499
Gnomad AMI
AF:
0.549
Gnomad AMR
AF:
0.584
Gnomad ASJ
AF:
0.530
Gnomad EAS
AF:
0.663
Gnomad SAS
AF:
0.509
Gnomad FIN
AF:
0.565
Gnomad MID
AF:
0.520
Gnomad NFE
AF:
0.492
Gnomad OTH
AF:
0.527
GnomAD2 exomes
AF:
0.532
AC:
130899
AN:
246148
AF XY:
0.526
show subpopulations
Gnomad AFR exome
AF:
0.492
Gnomad AMR exome
AF:
0.620
Gnomad ASJ exome
AF:
0.529
Gnomad EAS exome
AF:
0.665
Gnomad FIN exome
AF:
0.549
Gnomad NFE exome
AF:
0.494
Gnomad OTH exome
AF:
0.524
GnomAD4 exome
AF:
0.507
AC:
729107
AN:
1438268
Hom.:
194106
Cov.:
109
AF XY:
0.506
AC XY:
362192
AN XY:
715934
show subpopulations
African (AFR)
AF:
0.495
AC:
16488
AN:
33286
American (AMR)
AF:
0.615
AC:
27402
AN:
44544
Ashkenazi Jewish (ASJ)
AF:
0.525
AC:
13557
AN:
25820
East Asian (EAS)
AF:
0.701
AC:
27805
AN:
39692
South Asian (SAS)
AF:
0.503
AC:
43215
AN:
85874
European-Finnish (FIN)
AF:
0.547
AC:
28731
AN:
52480
Middle Eastern (MID)
AF:
0.520
AC:
2996
AN:
5760
European-Non Finnish (NFE)
AF:
0.494
AC:
538613
AN:
1091184
Other (OTH)
AF:
0.508
AC:
30300
AN:
59628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
28363
56726
85088
113451
141814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15660
31320
46980
62640
78300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.517
AC:
76814
AN:
148652
Hom.:
20589
Cov.:
30
AF XY:
0.522
AC XY:
37875
AN XY:
72526
show subpopulations
African (AFR)
AF:
0.500
AC:
20261
AN:
40544
American (AMR)
AF:
0.584
AC:
8853
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
0.530
AC:
1807
AN:
3412
East Asian (EAS)
AF:
0.664
AC:
3375
AN:
5086
South Asian (SAS)
AF:
0.508
AC:
2405
AN:
4734
European-Finnish (FIN)
AF:
0.565
AC:
5670
AN:
10036
Middle Eastern (MID)
AF:
0.500
AC:
143
AN:
286
European-Non Finnish (NFE)
AF:
0.492
AC:
32710
AN:
66434
Other (OTH)
AF:
0.531
AC:
1096
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1826
3652
5477
7303
9129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.457
Hom.:
4941
Bravo
AF:
0.516
TwinsUK
AF:
0.487
AC:
1805
ALSPAC
AF:
0.486
AC:
1873
ESP6500AA
AF:
0.463
AC:
1966
ESP6500EA
AF:
0.473
AC:
3991
ExAC
AF:
0.520
AC:
62813

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.85
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.027
DANN
Benign
0.50
DEOGEN2
Benign
0.030
T
Eigen
Benign
-2.4
Eigen_PC
Benign
-2.5
FATHMM_MKL
Benign
0.0043
N
LIST_S2
Benign
0.12
T
MetaRNN
Benign
0.0000027
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
-1.4
N
PhyloP100
-1.8
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.52
N
REVEL
Benign
0.083
Sift
Benign
1.0
T
Vest4
0.010
ClinPred
0.0019
T
GERP RS
-3.2
Varity_R
0.047
gMVP
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2943512; hg19: chr11-1272226; COSMIC: COSV71594159; COSMIC: COSV71594159; API